EFFECT OF NON-H-2-LINKED GENES ON ANTI-VIRUS IMMUNE-RESPONSES AND LONG-TERM SURVIVAL IN MICE PERSISTENTLY INFECTED WITH E-55+ MURINE LEUKEMIA-VIRUS

被引:10
作者
AVIDAN, N
TUMASBRUNDAGE, KM
SIECK, TG
PRYSTOWSKY, MB
BLANK, KJ
机构
[1] MED COLL PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19102
[2] HAHNEMANN UNIV,PHILADELPHIA,PA 19102
[3] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107
[4] ALBERT EINSTEIN COLL MED,MONTEFIORE MED CTR,DEPT PATHOL,BRONX,NY 10462
关键词
D O I
10.1006/viro.1995.1432
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have previously demonstrated that BALB/c-H-2(k) (BALB.K) mice are susceptible to the development of thymic lymphoma induced by E-55+ murine leukemia virus (MuLV). In the present studies, C57BL/10-H-2(k) (B10.BR) mice were found to be resistant to E-55+ MuLV-induced lymphoma despite the fact that these mice become persistently infected. This resistance to lymphomagensis is mediated by the anti-virus immune response since immunosuppressed mice progress to develop disease. The protective immune response in B10.BR mice is bimodal with respect to time after virus infection. The early immune response results in a dramatic decrease in the number of virus-infected cells within 4-8 weeks after infection. This decrease in virus-infected cells occurs in immunocompetent mice from strains that are either resistant (B10.BR) or susceptible (BALB.K) to E-55+ MuLV-induced disease. Subsequently, susceptible mice develop an increase in infected cells, whereas no increase in infected cells occurs in resistant mice despite the fact that they are persistently infected. This later phase of resistance in B10.BR appears to be mediated by T cells. Since B10.BR and BALB.K both express the H-2(k) haplotype, resistance appears to be mediated by a non-H-2-linked gene(s). (BALB.K x B10.BR)F-1 mice are resistant to disease development, indicating resistance is a dominant trait. (C) 1995 Academic Press, Inc.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 37 条
[1]   H-2D (RFV-1) GENE INFLUENCE ON RECOVERY FROM FRIEND-VIRUS LEUKEMIA IS MEDIATED BY NON-LEUKEMIC CELLS OF THE SPLEEN AND BONE-MARROW [J].
BRITT, WJ ;
CHESEBRO, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (06) :1795-1804
[3]   CHARACTERIZATION OF MOUSE MONOCLONAL-ANTIBODIES SPECIFIC FOR FRIEND MURINE LEUKEMIA VIRUS-INDUCED ERYTHROLEUKEMIA-CELLS - FRIEND-SPECIFIC AND FMR-SPECIFIC ANTIGENS [J].
CHESEBRO, B ;
WEHRLY, K ;
CLOYD, M ;
BRITT, W ;
PORTIS, J ;
COLLINS, J ;
NISHIO, J .
VIROLOGY, 1981, 112 (01) :131-144
[4]  
CHESEBRO B, 1978, J IMMUNOL, V120, P1081
[5]   HOST GENETIC-CONTROL OF SPONTANEOUS AND INDUCED IMMUNITY TO FRIEND MURINE RETROVIRUS INFECTION [J].
CHESEBRO, B ;
MIYAZAWA, M ;
BRITT, WJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :477-499
[6]   CHARACTERIZATION OF MONOCLONAL-ANTIBODIES REACTIVE WITH MURINE LEUKEMIA VIRUSES - USE IN ANALYSIS OF STRAINS OF FRIEND MCF AND FRIEND ECOTROPIC MURINE LEUKEMIA-VIRUS [J].
CHESEBRO, B ;
BRITT, W ;
EVANS, L ;
WEHRLY, K ;
NISHIO, J ;
CLOYD, M .
VIROLOGY, 1983, 127 (01) :134-148
[7]   ANTIBODY-INDUCED MODULATION OF FRIEND-VIRUS CELL-SURFACE ANTIGENS DECREASES VIRUS PRODUCTION BY PERSISTENT ERYTHROLEUKEMIA-CELLS - INFLUENCE OF THE RFV-3 GENE [J].
CHESEBRO, B ;
WEHRLY, K ;
DOIG, D ;
NISHIO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5784-5788
[8]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[9]   GENETIC-VARIATION IN AIDS VIRUSES [J].
COFFIN, JM .
CELL, 1986, 46 (01) :1-4
[10]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964